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Abstract
Background
Translational control is a mechanism of protein synthesis regulation emerging as an impor-
tant target for new therapeutics. Naturally occurring microRNAs and synthetic small inhibi-
tory RNAs (siRNAs) are the most recognized regulatory molecules acting via RNA
interference. Surprisingly, recent studies have shown that interfering RNAs may also acti-
vate gene transcription via the newly discovered phenomenon of small RNA-induced gene
activation (RNAa). Thus far, the small activating RNAs (saRNAs) have only been demon-
strated as promoter-specific transcriptional activators.
Findings
We demonstrate that oligonucleotide-based trans-acting factors can also specifically
enhance gene expression at the level of protein translation by acting at sequence-specific
targets within the messenger RNA 5’-untranslated region (5’UTR). We designed a set of
short synthetic oligonucleotides (dGoligos), specifically targeting alternatively spliced
5’UTRs in transcripts expressed from the THRB and CDKN2A suppressor genes. The in
vitro translation efficiency of reporter constructs containing alternative TRβ1 5’UTRs was
increased by up to more than 55-fold following exposure to specific dGoligos. Moreover, we
found that the most folded 5’UTR has higher translational regulatory potential when com-
pared to the weakly folded TRβ1 variant. This suggests such a strategy may be especially
applied to enhance translation from relatively inactive transcripts containing long 5’UTRs of
complex structure.
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Significance
This report represents the first method for gene-specific translation enhancement using
selective trans-acting factors designed to target specific 5’UTR cis-acting elements. This
simple strategy may be developed further to complement other available methods for gene
expression regulation including gene silencing. The dGoligo-mediated translation-enhanc-
ing approach has the potential to be transferred to increase the translation efficiency of any
suitable target gene and may have future application in gene therapy strategies to enhance
expression of proteins including tumor suppressors.
Introduction
Translational control is one of the most important mechanisms of post-transcriptional regula-
tion of gene expression, determining final protein levels [1]. Initiation of translation [2] is a
rate-limiting phase of protein synthesis, controlled by translation -silencing or -enhancing cis-
acting elements located in the 5’ and 3’ untranslated regions (5’UTR, 3’UTR) of mRNAs [3].
The best studied cis-acting elements within the UTRs are the upstream open reading frames
(uORFs) [4] and internal ribosomal entry sites (IRESs) [5]. These regulatory sequences may be
organized in secondary and tertiary RNA structures that are recognized by trans-acting factors
[6] such as translation factors [7], naturally occurring microRNAs (microRNAs) [8] as well as
synthetic small interfering RNAs (siRNAs) [9] and antisense-like oligonucleotides (ASOs) usu-
ally lowering final protein levels [10].
Translation of most human mRNAs occurs via a 5’-cap-dependent mechanism [11]. Certain
physiological or pathological factors may switch the classic mechanism to an alternative one
that can be controlled by an mRNA element such as uORF, IRES, iron responsive element
(IRE), RNA hypoxia response element (rHRE), differentiation-control element (DICE) or cap-
independent translational enhancer (CITE) [12, 13]. An alternate cap-independent IRES-
dependent translation [5, 13] is activated in some cellular phases such as cell division [14] and
during integrated stress responses (ISR) [15] caused by heat shock, serum or amino-acid depri-
vation and in hypoxia, as frequently observed in solid tumors [16]. Expression of specific genes
involved in the stress responses can be also controlled by uORFs [4, 13]. ISR-enhanced synthe-
sis of ATF4 (Activating Transcription Factor 4) protein is an extensively-studied model of the
translational control [4]. This mechanism involves the differential contribution of two uORFs:
the 5’ proximal uORF1 that is a positive cis-acting element and the inhibitory uORF2 overlap-
ping correct ATF4 ORF in an out of frame manner. Non-stressed, normal conditions allow
cells for fast translation of the short uORF1 and ribosome reinitiation at the uORF2, that
results in synthesis of truncated proteins. In contrast, stress conditions increase the time
required for more accurate scanning that allows the ribosomes to bypass the inhibitory uORF2
and reinitiate at the downstream ATF4-coding region [4]. Translation initiation can also be
slowed down by various interfering trans-acting factors [1] or highly-ordered RNA structures
[17], which require RNA helicases to be scanned through [3, 13]. Moreover, 5’UTR structures,
recruiting RNA helicase eIF4A2, have now been demonstrated to play a crucial role in 3’UTR-
dependent, microRNA-mediated gene silencing [18]. Therefore, efficiency of various mecha-
nisms involved in translation initiation has been thought to be dependent on the folding state
of 5’UTRs, determined by the Gibbs energy (ΔG) [17].
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Many genes have several alternative 5’UTR splice variants that can differentially regulate
translation of downstream coding sequences [6]. One example of such a complex gene is
THRB (GeneID 7068), which encodes β isoforms of human thyroid hormone receptors (TRβ1,
TRβ2 and TRβ4) [19] and contains numerous alternatively spliced exons that generate various
alternate 5’UTRs in mRNAs from which the TRβ tumor suppressor protein is expressed [19,
20]. Multiple strongly folded 5’UTRs can also be expressed by another tumor suppressor–
CDKN2A (GeneID 1029) [21]. Both genes encode 5’UTRs containing numerous uORFs [21,
22] and IRES-like sequences [21, 23]. These 5’UTRs vary in length, GC-content and secondary
structure and have been shown to influence the efficiency of protein translation [21, 23].
Recent studies have revealed that some naturally occurring microRNAs, considered tradi-
tionally as inhibitory trans-acting factors that bind to 3’UTR sequences, can also up-regulate
protein synthesis [24]. Moreover, it has been discovered that several mRNAs contain similar
microRNA targets termed miBridges present in both 3'UTR and 5'UTR regions that can bind
the same microRNA molecule [25]. Further supporting the hypothesis of microRNA binding
to 5’UTRs, a liver-specific microRNA, miR-122 has been shown to stimulate synthesis of hepa-
titis C virus (HCV) protein by direct interaction with two target sites in the 5’UTR of the HCV
genome [26]. Even though a single microRNA usually targets possibly hundreds of cellular
mRNAs [27], showing low selectivity towards transcripts of a single gene [28], these findings
demonstrate a new role of short interfering RNAs that may lead not only to gene repression,
but also to protein synthesis enhancement.
Recently, a new type of RNA interference has been shown to result from promoter-specific
activation of gene transcription (RNAa, RNA activation) that is triggered by a novel class of
interfering RNAs termed small activating RNAs (saRNAs), which target discrete promoter
sequences [29]. The saRNAs were used for promoter-specific upregulation of gene transcrip-
tion [30]. On the other hand, the saRNAs were alternatively reported to represent siRNAs that
bind to and inhibit long naturally occurring antisense transcripts (NATs) overlapping comple-
mentary promoter regions of target genes, which play a role in transcriptional repression [31,
32]. Thus, silencing of the NATs could indirectly lead to transcriptional activation of the genes
[33, 34]. Both mechanisms of gene regulation, however, have been shown to control only the
levels of mRNA expression [31, 33].
Here we describe a novel method for 5’UTR-specific enhancement of translation. Protein
overexpression is triggered by synthetic, translation-enhancing oligonucleotides, termed dGoli-
gos (dGs), which were originally designed to alter Gibbs energy-dependent secondary structure
formation of specific sequences of TRβ1 5’UTRs. Although ΔG is a well-known measure of the
stability of higher-order structures of nucleic acid molecules, we used this parameter in a new
way, defined in a bespoke dGenhancer calculator. This tool allowed us to determine cis-acting
elements within TRβ1 5’UTRs that were recognized by dGs. Then, the translation-enhancing
effects were successfully confirmed by the use of dGs design to target p16INK4a 5’UTR encoded
by the CDKN2A gene. dGoligos thus offer the potential for a novel and specific gene-therapy
approach to re-express or over-express individual proteins such as tumor suppressors.
Results
Translation regulated by differentially folded TRβ1 5’UTRs
TRβ1 5’UTR splice variants A-G subcloned upstream of the luciferase reporter gene in pKS
plasmids [22] were tested for their basic expression characteristics by coupled in vitro tran-
scription-translation (RTS 100 Wheat Germ CECF). The basic luciferase levels served as start-
ing points for further studies on translation-enhancing elements of the 5’UTRs. Initial results
demonstrated that variants A-G differently regulate the reporter protein translation efficiency
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(Fig 1a and 1b). The measurements were shown in relation to control plasmid (pKS-control)
containing an irrelevant synthetic vector-based leader sequence (ΔG = −6.8 kcal/mol) lacking a
TRβ1 UTR (see Materials and Methods). We found that the basic luciferase expression rates
were the highest (24.09% of the control, p<0.001) when driven by the most weakly folded vari-
ant A, possessing the lowest (negative) value of Gibbs energy (ΔG = −69.0 kcal/mol, Fig 1b). In
contrast, luciferase expression from plasmids containing variant G (ΔG = −127.0 kcal/mol)
and the most folded variant F (ΔG = −128.9 kcal/mol) was strongly inhibited (3.00% and
4.03% of the control for variant G and F respectively, p<0.001). Similar effects were previously
reported in human placental JEG-3 choriocarcinoma cells [22] and in Caki-2, a human clear
cell renal cell carcinoma line [23]. To check whether the different luciferase protein levels
resulted from changes in levels of particular transcripts, we quantified luciferase mRNAs after
6h of the coupled transcription-translation reaction. Real-time PCR revealed no significant dif-
ferences in luciferase transcription rates driven from the tested variants A-G (Fig 1a). These
results are consistent with previous observations in Caki-2 cells [23] and in another in vitro
translation system based on rabbit reticulocyte lysates [22].
Fig 1. Correlation between Gibbs energy and basic TRβ1 5'UTR-mediated translation efficiency. (a) Luciferase mRNA levels from in
vitro wheat germ-based coupled transcription-translation assay performed on plasmids containing TRβ1 5’UTR variants A-G are shown
relative to control plasmid. (b) Effects of 5’UTR variants A-G on luciferase activities after 6h coupled transcription-translation. Three
independent experiments were performed in triplicate and shown as mean%mRNA or luciferase activity± SD. Data were analyzed by
ANOVA followed by Dunnett’s multiple comparison test; *p< 0.001 vs. control. c, Correlation between the calculated Gibbs energies (X
axis) of each 5’UTR variant (S1 Table) and UTR-mediated luciferase translation efficiency. The correlation is shown as the exponential
trend-line y = 127.29*e
0,0248*X, where x = calculated Gibbs energy; Pearson product-moment correlation coefficient r² = 0,9746.
Logarithmically transformed data of translation efficiency (Y axis) were analyzed together with Gibbs energies by linear regression;
p = 0.0123.
doi:10.1371/journal.pone.0155359.g001
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Correlation between Gibbs energy and translation efficiency
Although multiple bioinformatic tools for the analysis of higher-order structures of RNA are
available, their utility in predicting the effects of translation -silencing or -enhancing cis-acting
elements on the levels of protein expression is limited [35]. These elements may require specific
secondary and tertiary folding to exert their normal function and may regulate the translation
of downstream sequences independently of their nucleotide composition and Gibbs energy
(ΔG) status [4, 36]. Therefore, we investigated whether the Gibbs energy of TRβ1 5’UTRs (S1
Table) could correlate with 5’UTR-controlled translation efficiency of a downstream ORF.
High Pearson’s correlation coefficient r2 = 0.9746 (p<0.005) showed that protein levels are
strictly dependent on Gibbs energies of the TRβ1 5’UTRs (Fig 1). The correlation also resulted
in an exponential equation (y = 140.46e0,0307
X, Fig 1c) that could serve for theoretical predic-
tion of the translation rate of any TRβ1 5’UTR variant. An example application of this equation
is shown in S2 Table. Finally, the correlation allowed us to use ΔG-based algorithm derived
from the dGenhancer calculator for an automatic design of oligonucleotide trans-acting factors
(S1 Appendix).
Prediction of cis-acting-elements of high regulatory importance
Since most of the alternatively spliced variants of TRβ1 5’UTRs were shown to have strongly
folded, translation-inhibiting sequences [22, 23], further study was performed to estimate
their translational potential and find a method that could release the potential to enhance pro-
tein synthesis. We aimed to identify sequences within TRβ1 5’UTRs that could be of particular
importance in this process. At first, structures of the TRβ1 5’UTR variants A and F (S1 Fig)
were drawn with RNAstructure version 5.2 [37] to determine the most stable secondary struc-
tures accompanied by the most negative ΔG. These folding predictions allowed us to identify
elements that are likely to be required for secondary and tertiary folding of the 5’UTRs. Then,
the elements were compared with publicly known cis-acting sequences of IRESite database
[38] that allowed us to identify common sequence motifs of possible functional importance.
We selected a hairpin sequence within a previously reported domain containing a putative
IRES, which has been identified before in the TRβ1–5'UTRs [23], and a sequence conserved
among all TRβ1 5’UTR variants with multiple alternate AUGs [22] (Fig 2). To check func-
tional properties of the putative IRES site, we performed a simple test in Caki-2 cells, cultured
in serum-deprived medium, which has been reported to switch between cap-dependent and
cap-independent (IRES-mediated) translation [5, 12]. We found that protein synthesis rates
after serum starvation resulted in higher luciferase activity from plasmid containing the TRβ1
IRES site (pGL3-A) [22] compared to the control (pGL3-control) [22] without the IRES
sequence (S2 Fig).
Finally, the manually selected translation -enhancing element e1 (IRES) and translation
-inhibiting element e3 (uORFs, Fig 2) were compared with automatically determined elements
identified by the dGenhancer. The calculator works on the basis of ΔG changes observed
among in silico generated 5’UTR sequence variants that differ in a single nucleotide substitu-
tion (SNP) altering overall ΔG of the sequences. These artificial variants were created by substi-
tution (base by base) in each nucleotide position of the 5’UTRs (S1 Appendix). Comparing
these two approaches we found that the manually and automatically determined elements of
the 5’UTRs are fairly similar with one exception of the strongest signal of dGenhancer showing
an additional translation-inhibiting element marked as e2 (Fig 2), located in exon 2a, which is
present in all TRβ1 5’UTR variants. Identification of these cis-acting elements allowed us to
design and synthesize specific oligonucleotide-based trans-acting factors, termed dGoligos
(dGs, Fig 2, S3 Table), designed to recognize and bind the predicted 5’UTR sequences.
AMethod for Gene-Specific Enhancement of Protein Translation
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dGoligo design and synthesis
We next evaluated whether we could selectively alter the Gibbs energy-dependent secondary
structure formation of TR1 5’UTRs using oligonucleotide—based trans-acting factors. We syn-
thesized a set of DNA oligonucleotides (dGoligos) directed to interfere with previously identi-
fied TRβ1 5’UTR cis-acting elements. High translational regulatory potential was defined as the
potential of the translation-regulating elements to enhance protein synthesis from low to high
rates. This regulation is thought to be controlled by distant cis- or trans-acting factors specifi-
cally binding to the regulatory elements (Fig 3d). A putative IRES [23] site and a sequence con-
taining multiple alternate AUGs [22] were targets for dGoligos (dGs) dG1, dG2, dG5, dG6 and
dG3, dG4 respectively (Fig 2). dG7 and dG8 were designed to target a sequence located in the
middle of exon 2a, identified by the dGenhancer to have the highest regulatory potential. For in
vitro assays, dGs were synthesized as sense-, antisense- or microRNA-like DNA oligonucleotides
(S3 Table). 2’-O-methyl RNA-modified derivatives were synthesized for in vivo assays.
dG-mediated linearization of 5’UTRs was predicted to disturb inhibitory structures and/or
liberate translation-enhancing elements. These proposed functions of the synthetic
Fig 2. dGoligo recognition sites. (a) Cis-acting elements (e1, e2, e3) of variant A of TRβ1 5’UTR determined by dGenhancer, which
indicates signal maxima (a.1, a.2 and a.3) corresponding to the 5’UTR fragments with the highest translational regulatory potential. The
signal intensity represents transformed mean of 6 consecutive changes in Gibbs energy (ΔG) observed among 5’UTR sequences
containing artificial SNPs. The SNPs were used as a theoretical model to calculate which sequence fragments (within the UTR) can change
ΔGs (of the UTR) the most, thereby affecting the translational potential of the 5’UTR. (b) dGoligo (dGs 1–10) targets (e1, e2, e3) in TRβ1
5’UTR are shown as underlined sequences. dGs are presented above (sense) and below (antisense) the TRβ1 5’UTR A. Each dG shares
homology with the TRβ1 5’UTR, targeting one of the indicated sequences: a putative IRES site on ex1c/ex2a junction (underlined) targeted
by dG1, dG2, dG5, dG6, a sequence containing multiple alternate AUGs (uORFs-rich region) and located on ex2a/ex3 junction targeted by
dG3, dG4 or a sequence in the middle of exon 2 targeted by dG7 dG8, dG9 and dG10. All dGs were designed as complementary pairs of
antisense strand (dG2, dG4, dG6, dG8, dG10) directly recognizing the indicated region and sense strand (dG1, dG3, dG5, dG7, dG9) that
can bind to distant sequences that interact through complimentary base-pairing with the indicated region (S1 Fig). Oligonucleotides dG5,
dG6, dG9 and dG10 were synthesized as microRNA-like oligonucleotides with 3-nt insertion in the middle of their sequences.
doi:10.1371/journal.pone.0155359.g002
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oligonucleotides were likely to be required for structural rearrangement of the 5’UTRs into
their translationally active conformation (Fig 3) that facilitates interaction with naturally
occurring elements directly controlling final protein levels.
Translation-enhancing dGoligos targeting TRβ1 5'UTRs
The influence of dGoligos on translation efficiency was studied in coupled in vitro transcrip-
tion-translation reactions using plasmids containing the least (A) and the most (F) folded vari-
ant of TRβ1 5’UTR cloned upstream of luciferase reporter. Effects of each dGoligo on protein
synthesis were assessed in a translation-enhancing assay. Levels of luciferase mRNA and pro-
tein (luciferase activity) expressed from plasmid without or with dGoligo supplementation
were measured by Real-Time PCR and luminometry. Maximum luciferase activity was
observed after 6h (S3 Fig) and this time point was chosen for subsequent analyses. No statisti-
cally significant differences in luciferase mRNA levels were observed between control and plas-
mid constructs.
To eliminate the effects of possible non-specific dG-plasmid interactions, all transcription
and translation measurements for both pKS-A and pKS-F plasmids were standardized to
mRNA levels driven from control plasmid with a short irrelevant vector-based leader sequence
that contained no specific dGoligo binding sites (pKS-control).
dG1 and dG2 were synthesized as a pair of complementary, sense- and antisense- DNA oli-
gonucleotides. dG1 shares sequence with the most stable secondary structure of the
Fig 3. Folding states of TRβ1 5’UTRs. Translation efficiency of TRβ1 is dependent on folding states of its 5'UTR, which is proposed to be:
strongly folded (a), partially unfolded (b) or fully unfolded following interaction with dG1 and dG4 (c). The 5’UTR is shown as curve ended by
an arrow at AUG translation start codon. Two linked ovals assigned by letter R represent ribosome that may be blocked by distant cis-acting
element (cis-a.e) or trans-acting factor (dG1 or dG4). AUG start codon is preceded by selected translation-regulating elements (e1 and e3).
Translation-enhancing element e1 contains putative Internal Ribosome Entry Site (IRES) that may be involved in enhancement of cap-
independent translation initiation. Translation-silencing element e3 contains upstreamOpen Reading Frames (uORFs)–rich region that can
reduce translation initiation from correct AUG start codon due to simultaneous synthesis of truncated proteins originated from upstream
AUGs (shown by inverted ribosome). a, Theoretical folding state of TRβ1 5'UTR characterized by the presence of highly-structured
sequence that can block both: translation-enhancing e1 and translation-silencing e3, finally leading to only basal protein synthesis. (b)
Another theoretical folding state described by partially unfolded 5’UTR with blocked e1 and unblocked e3, resulting in basal translation rates
as well. (c) Proposed model of dG1 and dG4 -mediated enhancement of translation efficiency, wherein antisense dG4 could lead to
repression of uORFs within e3, whereas binding of sense dG1 to a distant sequence (usually folded with e1) could release this translation-
enhancing region, allowing for protein over-expression (additional description is given in S4 Fig). (d) dGoligo (dG) targets on mRNA.
Locations of dG binding sites are shown in the context of typical targets of the most known small interfering RNAs. microRNA (2, 5), siRNA
(3), saRNA (1) and ASO (4), are shown by short grey arrows. Newly described interactions that may result in up-regulation of gene
expression are indicated by asterisk*.
doi:10.1371/journal.pone.0155359.g003
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translation-enhancing element e1 (Fig 2) containing a putative IRES site [23] (S4g1 Fig) while
sequence of dG2 is complementary to this region. As a result, dG1 increased translation effi-
ciency over 1.29-fold when using pKS-A and 2.90-fold in case of the use of pKS-F (p<0.001,
Fig 4b and 4d), while dG2 decreased the protein levels by 1.80-fold for pKS-A and did not alter
translation for pKS-F, probably due to the lack of 3’-end of exon 1c in the variant F (S1b Fig).
Since the sense dG1 has the same sequence as e1 element of the 5’UTR, it can interact with and
block the homologous distant mRNA sequences (cis-acting elements) (Fig 3a) that can fold
with the e1 domain [23] and lead to its repression. Thus, dG1 was designed to release the
domain allowing for appropriate folding of this sequence that appears to be required for effi-
cient translation. Antisense dG2, complementary to e1 sequence, was designed to bind this
region directly, preventing formation of an active sequence conformation (S4 Fig).
dG3 (sense) and complementary dG4 (antisense) were designed to target sequence at ex2a/
ex3 junction of TRβ1 5’UTR (e3 in Fig 2) that contains numerous upstream translation start
cordons—uAUGs (S4h1 Fig). The sense dG3 has the same sequence as the uORFs-rich domain
of the 5’UTR, and thus may interact with distant cis-acting elements (Fig 3a), which normally
can fold with uAUG-rich domains [22] and act as uORF inhibitors allowing for more efficient
translation from the canonical start codon. Thus, dG3 was designed to release the uORFs-rich
domain of the mRNA, and was expected to facilitate initiation of translation from upstream
AUGs (S4h1 Fig) resulting in reduced initiation of protein synthesis from the correct AUG
start codon (Fig 4b and 4d). By contrast, antisense dG4 was designed to bind the mRNA
sequence containing the uAUGs to render the uAUG-rich region inaccessible for the transla-
tion machinery (S4b1 Fig), resulting in enhanced translation initiation from the correct AUG
start codon. These predictions were supported by results showing that dG3 decreased transla-
tion efficiency by 2.40-fold for pKS-A and 7.25-fold for pKS-F (p<0.001), whereas addition of
dG4 increased translation efficiency by 1.33-fold for pKS-A and 1.86-fold for pKS-F
(p<0.001). The findings suggest that blockade of alternate uAUGs is important for efficient
protein translation and are consistent with results showing that initiation codons located
upstream of the correct start codon of the TRβ1 can markedly affect the efficiency of protein
synthesis [4, 22]. The translation-enhancing action of dG4 could also be explained using a
model of enhancement of ATF4 translation in stress conditions, which can switch off inhibitory
uORFs by increasing the time of 5’UTR scanning [4]. This allows for ribosomes to bypass the
uORFs and find the correct ATF4 start codon in the Kozak consensus sequence [4, 13]. Our
results show that binding of dG4 to TRβ1 uORFs-rich region forms a double stranded sequence
that possibly slows down the scanning machinery. Thus, the use of dG4 may delay translation
initiation, as it is observed in stress conditions, leading to enhanced levels of correct proteins.
Moreover, the uORF-regulated translation initiation in stress conditions is found to be accom-
panied by higher translation rates of IRES-containing mRNAs [4, 13]. Indeed, our in vitro
experiments showed that combined addition of sense dG1 and antisense dG4 increased lucifer-
ase activity by 1.77-fold (p<0.001, Fig 4b) from pKS-A and 6.58-fold from pKS-F (p<0.001,
Fig 4d). The translation-enhancing effect could result from simultaneous release of the transla-
tion-enhancing element (e1) [23] and block of the uORFs-rich region [22] (Fig 3c). These
results may also suggest that strongly folded variant F could be characterized by a higher trans-
lational regulatory potential (S2 Table and S5 Fig).
Furthermore, analysis of dG7 and dG8, designed on the basis of a cis-acting element
detected by dGenhancer (S3 Table), revealed that dG8 enhanced translation by 6.02-fold and
8.30-fold for pKS-A and pKS-F respectively, whereas sense dG7 had no significant effect (Fig
4a and 4b). Interestingly, a combination of antisense dG8 and sense dG1 enhanced luciferase
activity over 28.1- (pKS-A) and 55.8-fold (pKS-F) (p<0.001). These effects reinforce the find-
ing that exon 2a is conserved in all TRβ1 alternatively spliced 5’UTR variants and suggest an
AMethod for Gene-Specific Enhancement of Protein Translation
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important role in translation control from this locus. Thus, blocking of exon 2 with comple-
mentary antisense dG8 resulted in the strongest enhancement of translation, indicating that
the cis-acting element at this site (e2) is not affected by other distant sequences of the 5’UTRs
and has a key inhibitory role in translational control of TRβ1. These findings support the
hypothesis that dGenhancer may be used to identify ΔG-dependent, translation-regulating ele-
ments in 5’UTRs that could be targeted by dGs to alter their Gibbs folding energy and regulate
the translation efficiency. Finally, the data suggest a role for the multiple alternatively spliced
TRβ1 5’UTRs. Strongly folded variants (including variant F) may serve as a reservoir of less-
active mRNAs that could be recruited to increase translation efficiency at times of cellular
stress, for example, by the use of specific trans-acting factors such as ncRNAs. Interestingly,
bioinformatic analysis of microRNA target sites within TRβ1 untranslated regions revealed
that hsa-miR-211 could potentially target both TRβ1 3’UTR and 5’UTR (S6a and S6b Fig) and
binding of this non-selective ncRNA could at least affect secondary structures of the UTRs.
Indeed, 2’-O-methyl RNA modified hsa-miR-211 enhanced TRβ1 5’UTR-mediated translation
by 1.95-fold in Caki-2 cells (S6c Fig).
dGoligo controls and binding capacity
All the results presented above show that, in contrast to translation-enhancing dGs, their com-
plementary control partners (antisense dG2, sense dG3 and sense dG7) had no or opposite
effects (Fig 4b and 4d), thus confirmed target site-specific action of sense dG1, antisense dG2
and antisense dG8. The fact that both sense and antisense oligonucleotides directed to bind
5’UTRs seriously altered translation levels gives a new insight into the nature of these molecules
and indicates that this action may depend on specific properties of a target cis-acting element.
Fig 4. dGoligo-mediated gene expression changes under in vitro conditions. Effects of each DNA oligonucleotides dG1-dG10 (S3
Table), on in vitro transcription of luciferase reporter constructs (panels a, c) and translation efficiency (b, d), using pKS-A (a, b) or pKS-F
plasmid (c, d). Data normalized to control (dG-) containing pKS-A or pKS-F without addition of dGoligo. Scrambled control (dGsc) had no
effect on transcription or translation. The strongest enhancing effects on luciferase activity were obtained by combining dG1+dG8
(28.10-fold from pKS-A and 55.80-fold from pKS-F). Results from three independent experiments performed in triplicates are shown as
mean%mRNA (a, c) or luciferase activity (b, d) ± SD. Data analyzed by ANOVA followed by Dunnett’s multiple comparison test. *p<0.001
vs. control.
doi:10.1371/journal.pone.0155359.g004
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Interestingly, these results also suggest that sense oligonucleotides, used in numerous studies as
a control to antisense nucleotides (ASOs), could actually interact with distant cis-acting ele-
ments, significantly changing translation efficiency as it was shown in our study (Fig 4d).
To check whether the sequence structure of the dGs has an impact on their function we syn-
thesizedmismatched control dG5 and control dG6 sharing the same sequence with dG1 and
dG2, respectively, but containing a 2–3 nucleotide long insertion in the middle of both oligonu-
cleotides (Fig 2 and S3 Table). Upon binding target sequence, these additional nucleotides
should form a loop that mimics metazoan microRNA structure and prevents perfect base pair-
ing with target TRβ1 5’UTR. By mutating the dGs instead of their target sequences, we avoided
problems with undesirable loss of functional properties of investigated 5’UTR cis-acting ele-
ments [3, 17]. Since numerous studies suggest that translationally active conformation of the
UTR variants is of greatest importance for the UTR-mediated translational control, it seems our
strategy was the best choice for subsequent control reactions. In addition, in vitro transcription-
translation assays were performed in wheat germ extract and, as reported, plant microRNAs
require nearly perfect base pairing with the target RNA to exert RNAi related effects [39]. There-
fore, mismatched dG5 and dG6 served as mutated controls for other dGs (S4e1 and S4f1 Fig)
and were expected not to exert any possible RNAi effects in the wheat germ translation system.
As a result, neither the control sense dG5 nor control antisense dG6 altered translation levels
(Fig 4b and 4d) that may provide a proof for selectivity of other fully complementary dGs. Simi-
lar microRNA-like controls were designed on the basis of another pair of dGs (dG7, dG8) and
termed dG9 and dG10 (S3 Table). The use of these oligonucleotides revealed no effects on
translation, supporting the observation that in the used plant-derived translation system, anti-
sense-like dGs need full complementarity to affect gene expression [39].
Additional scrambled control (dGsc) with a random sequence (S3 Table) was also shown to
have no effect on luciferase activity (Fig 4). dG binding assays revealed high binding capacity of
all tested antisense-like dGs that were complementary to pKS-A transcripts (S7 and S8 Figs).
Although sense-like dGs shared the same sequence with the variant A of the TRβ1 5’UTR
(pKS-A), they were able to bind RNA as well, however, with a lower capacity when compared to
the antisense dGs. At the same time, the binding of the scrambled control was undetectable (S7
Fig). These results may confirm our assumption that sense dGs can bind, at least partially, to the
distant inhibitory sequences of the TRβ1 5'UTR, releasing translation-enhancing elements nor-
mally blocked by secondary structures in a translationally less active transcripts (Fig 3c).
Protein up-regulation induced by p16 5'UTR-specific dGoligos
To test whether our approach could be applied to enhance expression of another gene, we used
published sequence data [21] as well as dGenhancer calculator to design dGs, specifically tar-
geting p16INK4a 5'UTR (NCBI Ac.: NM_000077.4), a transcript of CDKN2A tumor suppressor.
In this in vitro study, dG-mediated regulation of protein synthesis was tested using PCR-ampli-
fied linear expression construct containing T7 promoter, p16INK4a 5’UTR and the coding
sequence of luciferase allowing for fast and reliable measurements of protein levels (S1 Appen-
dix). The effects of each DNA-based dGs dG1p16-dG6p16 (S3 Table) were measured using
coupled in vitro transcription-translation assay (Fig 5). Results from semi-quantitative real-
time PCR, performed with luciferase specific primers (S4 Table), and measurements of lucifer-
ase activity revealed that negative control (dG-), scrambled control (dGscp16), dG5p16 and
microRNA-like dG3p16 and dG4p16 had no effects neither on transcription nor translation
efficiency. These results are in agreement with our data, including those showing no effects of
microRNA-like DNA dGs in wheat germ lysates (Fig 4). Sense dG1p16 and antisense dG2p16
were designed on the basis of an element e1 (S1c Fig) containing an IRES sequence [21]. In
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samples supplemented with sense dG1p16 we observed unchanged transcription that was
accompanied by strong translation-enhancing effect (4.78-fold, p<0.001). Similarly, dG2p16
elevated protein levels by 2.56-fold (p<0.001), however, this particular result could be a conse-
quence of higher mRNA levels (1.3-fold, p<0.001). These results may indicate that apart from
the explicit dG-mediated translation-enhancing effects, confirming findings obtained with
TRβ1 5'UTRs, some dGs can influence transcription machinery as well, thereby resembling the
action of saRNAs [29, 30]. Using a combination of dG1p16 and dG6p16 (Fig 5) we observed
over 12.30-fold increase in luciferase activity that is in accordance with previously observed
effects triggered by a mixture of sense and antisense dGs: dG1+dG8 or dG1+dG4 targeting
TRβ1 5'UTRs. All the results were normalized to control (dG-). Data from three independent
experiments were performed in triplicate and analyzed by ANOVA followed by Dunnett’s mul-
tiple comparison test. p< 0.001 vs. control.
dGoligo-mediated translation-enhancing effects in Caki-2 cells
To test our in vitro data in a cellular context, similar experiments were performed in Caki-2
cells using TRβ1 5’UTR A (pGL3-A) and appropriate dGs (Fig 6). Although unmodified deox-
yoligonucleotides can display some in vivo activity, they are subject to rapid degradation by
nucleases and are of limited utility in mammalian cells [40]. Therefore, we synthesized nucle-
ase-resistant, 2'-O-methyl RNA modified oligonucleotides, which do not activate the RNase H
pathway [41]. Fig 6b shows that each dG differently regulated reporter protein synthesis. After
transfection the cells with the DNA-based dGs targeting variant A of TRβ1 5’UTR there was no
significant effect on translation of luciferase reporter protein (S9 Fig). By contrast, RNA-based
dGs showed increased translation efficiency between 1.7–2.1-fold (dG1, dG3), while the action
of dG2 and dG4 resulted in 1.3–1.4-fold decrease in the reporter protein levels (Fig 6b). Sur-
prisingly, antisense microRNA-like dG6, which was previously used as a mismatched control
in in vitro assay, resulted in 2.6-fold increase in luciferase activity, whereas sense dG5 had no
significant effect on translation when compared to control without any dG (p<0.01). The simi-
lar effects were observed when using microRNA-like dG9 and dG10 (1.09- and 4.8-fold respec-
tively). These results showed a difference between the in vitro and in vivo studies, wherein the
Fig 5. dGoligo-mediated upregulation of CDKN2A expression. PCR-amplified linear luciferase expression construct containing 5’UTR
of p16INK4a (CDKN2A) was generated (S1 Appendix) and used as a template in coupled transcription-translation assay that was performed
as described in experiments with TRβ1 5'UTRs. (a) Luciferase mRNA levels after 6-hour in vitro reaction of the linear construct with a DNA-
based dGoligos dG1p16—dG6p16, dG1p16+dG6p16 or dGscp16 (S3 Table) targeting the p16INK4a 5'UTR. (b) Luciferase activity as a
measure of dG-mediated translational control. All data are shown as mean%mRNA (a) or luciferase activity (b) ± SD. Data were analyzed
by ANOVA followed by Dunnett’s multiple comparison test. *p< 0.001 vs. control.
doi:10.1371/journal.pone.0155359.g005
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TRβ1 5’UTR targeting microRNA-like dGs exerted the strongest enhancing effects on transla-
tion in Caki-2 cells. The observed difference compelled us to introduce an additional 2'-O-
methyl RNA modified scrambled control (dGsc) with an irrelevant (random) sequence that
was shown to produce no change in luciferase activity, thus, confirming the specificity of the in
vivo dG action. All the results of the luciferase activity after dG supplementation were normal-
ized to control pGL3-A plasmid (mock transfected group). Data from three independent
experiments were performed in triplicate. The Shapiro—Wilk test was used to determine nor-
mality of data distribution. Normally distributed data were analyzed using ANOVA followed
by Dunnett’s multiple comparison test.
Over-expression of endogenous TRβ1 proteins in dGoligo-treated cells
Translation-enhancing properties of selected dGs were confirmed in Caki-2 cells, where trans-
fection with dGs resulted in increased levels of endogenous TRβ1 protein and its downstream
target—type 1 iodothyronine deiodinase DIO1 [8, 23] (Fig 7). In this part of the study, Caki-2
cells were transfected with 2’-O-methyl-modified RNA-based dG6, dG10 or scrambled control
—dGsc and cultured (without any plasmid) according to the procedure used in transcription
and translation assay. dGs were selected on the basis of previously obtained results (Fig 6).
Semi-quantitative real-time PCR for TRβ1 (exon 2–3) and DIO1, as well as western blot for
TRβ1 and β-actin (Abcam plc, Cambridge, UK) were performed as described before [23]. Rela-
tive density of bands was quantified by densitometry and TRβ1 protein levels were normalized
to β-actin. Fig 7b and 7d show that the most efficient enhancement of translation was achieved
by action of antisense, microRNA-like dG10, which upregulated the endogenous TRβ1 protein
synthesis by over 2.3-fold, whereas TRβ1 mRNA levels remained unchanged (p<0.001, Fig 7a).
These results may provide evidence that translation of endogenous TRβ1 can be enhanced by
dGs resulting in modification of the functional response, as evidenced by over 2.5-fold increase
in expression of the DIO1 target gene (p<0.001, Fig 7c). Data from three independent experi-
ments were performed in triplicate and shown as mean values ± SD. Statistics were calculated
using t-test to compare cells transfected with dGs vs. dGsc. p<0.001.
Discussion
These studies demonstrate that specific enhancement of gene expression can be achieved at the
level of protein translation. We found this phenomenon to be triggered in a specific manner by
Fig 6. dGoligo-mediated gene expression changes in Caki-2 cells. Effects of 2’-O-methyl RNA oligonucleotides on luciferase
transcription (panel a) and translation (b) in Caki-2 cells transfected with pGL3-A. MicroRNA-like dG10 and microRNA-like dG6 exerted the
strongest translation-enhancing effects in Caki-2 cells (4.83-fold and 2.60-fold respectively). Results from three independent experiments
performed in triplicates are shown as mean%mRNA (a) or luciferase activity(b) ± SD. Data analyzed by ANOVA followed by Dunnett’s
multiple comparison test. *p<0.001 vs. control.
doi:10.1371/journal.pone.0155359.g006
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an exogenous synthetic small enhancing oligonucleotide—dGoligo (dG) targeting a specific
5'UTR cis-acting element.
Targeting 5’UTRs could be a novel way to control protein levels
As previously demonstrated, alternative splicing of TRβ1 5’UTR variants is impaired in human
clear cell renal cell carcinoma (ccRCC) and differential expression of multiple mRNA variants is
accompanied by varying levels of TRβ1 protein expression [23]. Although the functional signifi-
cance of these observations is not known in ccRCC, aberrant expression of alternative 5’UTRs
has been shown to contribute to carcinogenesis mediated by silenced tumor suppressors [42] or
activated oncogenes [43]. In the light of complex secondary structures of low copy number
TRβ1 5’UTRs including variant F [23] and evidence for selective protein synthesis of some alter-
natively spliced mRNA variants in oxygen deprived tumors or metastatic cancers [13, 16], it has
Fig 7. Effects of selected dGs on expression of endogenous TRβ1 in Caki-2 cells.Caki-2 cells were transfected with 2’-O-methyl-
modified RNA-based dG6, dG10 or scrambled control—dGsc and cultured (without any plasmid) according to the procedure used in
translation-enhancing assay (Materials and Methods). dGs were selected on the basis of previously obtained results (Fig 6). Expression of
TRβ1 mRNA (a), protein (b) and DIO1 mRNA (c) are shown in upper panel. Semi-quantitative real-time PCR was performed for TRβ1 (exon
2–3) and DIO1, as described before [23]. Data from three independent experiments were performed in triplicate and shown as mean
values ± SD. Statistics were calculated using t-test to compare cells transfected with dGs vs. dGsc. *p<0.001. (d) An example western blot
for TRβ1 and β-actin is shown in lower panel. Each band (dGsc, dG10, dG6) represents sample combined from nine protein lysates.
Relative density of bands was quantified by densitometry and TRβ1 protein levels were normalized to β-actin. (e) A simplified model of dG-
mediated upregulation of endogenous TRβ1 protein, which has been demonstrated before to act as a transcription factor activating
transcription of multiple genes including type 1 iodothyronine deiodinase (DIO1).
doi:10.1371/journal.pone.0155359.g007
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been suggested that the sequence diversification of TRβ1 5’UTRs could play an important role
in controlling THRB gene expression and this may influence tumor progression [23, 44]. Thus,
the reported lack of correlation between the mRNA and TRβ1 protein levels in ccRCC [23]
raised the hypothesis that the observed impairment may result, at least in part, from differing
translational efficiencies of the TRβ1 5’UTR variants. This hypothesis is supported by the corre-
lation observed between the in vitro translation efficiency of each 5’UTR and its Gibbs energy
(Fig 1c), resulting in the aim to evaluate whether translation efficiency could be altered specifi-
cally by affecting folding Gibbs energy (ΔG). To investigate further, we used oligonucleotide—
based trans–acting factors termed dGoligos (S3 Table) to selectively target TRβ1 5’UTRs and
change the Gibbs energy-dependent secondary structure formation of the 5’UTRs (Fig 2). Since
a misfolded conformation of mRNA cis-acting domains could result in either enhanced or
reduced protein translation [4, 5], direct binding to these domains (in case of antisense-like
dGs) or binding to distant cis-acting sequences folding with these domains (sense-like dGs) may
enhance or repress protein synthesis (Fig 3). To find ΔG-dependent, translation-regulating
domains we used a bespoke dGenhancer calculator, which allowed us to design the most effec-
tive, translation-enhancing dGs (S1 Appendix). However, this version of the calculator is unable
to show ΔG-independent, functionally-active elements including IRESs, therefore it should be
used together with other available databases of cis-acting elements.
Strongly folded 5'UTRs have higher regulatory potential
In this study, the strong enhancement of translation was achieved by coupled action of sense
dG1, designed to unblock a translation-enhancing element (e1), and antisense dG4, directly
binding to an inhibitory region (e3, Fig 2). When both dGs were added, 1.77-fold and 6.58-fold
increases in translation efficiency from weakly folded 5’UTR variant A and strongly folded vari-
ant F respectively were observed (Fig 4b and 4d). At the same time, the basal translation level
(control without any dG) (Fig 1b) of variant A (24.09% of control) was 5.96-fold higher when
compared to variant F (4.03% of control), suggesting that the folded variant F could possess
higher translational regulatory potential that was triggered by dG1 and dG4 (S5 Fig). These
results suggested the hypothesis that mRNAs containing strongly folded 5’UTRs may constitute
a pool of translationally non-active or less-active transcripts that could be recruited to transla-
tion through interaction with naturally occurring small RNAs [18, 34], which may interfere
with mRNA 5’UTRs in the same way as our dGs. This hypothesis is supported by the previously
reported observation that cellular microRNAmiR-10a can interact with the 5’UTR of mRNAs
encoding ribosomal proteins that results in enhancement of their translation and may be impli-
cated in tumor invasion and metastasis [45]. Here, we showed translation-enhancing effects of
synthetic, TR1 5'UTR-specific, microRNA-like dGs (Fig 6), however, we also found naturally
occurring microRNA hsa-miR-211 to have target sites in both TRβ1 3’UTR and 5’UTR (exon 2/
3, S6 Fig). Furthermore, recent studies on 3’UTR-mediated gene silencing showed a correlation
between microRNAs targeting 3’UTRs and 5’UTR structures, which can recruit RNA helicase
eIF4A2, a key factor of eIF4F through which microRNAs function [18]. The authors have dem-
onstrated that the eIF4A2 activity in 5’UTRs are critical for microRNA-mediated gene regula-
tion as well as that mRNAs with weakly folded 5’UTRs are refractory to microRNA repression
[18]. This report and our current results show that, in spite of low basal translation efficiency of
mRNAs containing highly-structured 5’UTRs (Fig 1b), these regions alone or together with
3’UTRs have higher translational regulatory potential compared to unfolded 5’UTR variants
(Fig 4b and 4d). It seems, therefore, that UTR-controlled translation-enhancing or -silencing
phenomena could be triggered in response to exposure to available trans-acting factors that may
lead not only to gene repression [9, 27] but also gene activation [30, 31].
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dGoligos can lead to over-expression of selected proteins
In vitro results revealed that both, sense and antisense dGs can trigger translation-enhancing
effects that appear to be mostly dependent on a specific function of a 5'UTR cis-acting element.
The action of sense dG1 was thought to increase protein synthesis by releasing translation-
enhancing element e1 (Fig 3c) containing a putative IRES domain that has been identified
before in the TRβ1–5'UTRs [23] and tested in Caki-2 cells (S2 Fig). The translation-enhancing
action of antisense dG4 and dG8, which are complementary to a highly structured region con-
taining multiple uAUGs, could be explained by linearization of their target sites and blocking
the uAUGs-rich region to prevent from translation of alternative polypeptides (Fig 3c). This
explanation is in agreement with a well-studied model of the selective enhancement of ATF4
protein synthesis during integrated stress response (ISR) [4, 13]. ISR can delay cap-dependent
translation that makes uAUGs less attractive as start codons and allows ribosomes to scan
through the inhibitory uAUGs to find the correct codon of ATF4 [4]. Similarly, antisense dG4
or dG8 could serve as a trans-acting factor making the TRβ1 uAUG-rich domain inaccessible
for the translation machinery, thus, facilitating the ribosomes to start the synthesis at the cor-
rect AUG. These antisense-mediated effects might be supported by cap-independent transla-
tion, initiated at the IRES domain [12] that is released by sense dG1. Indeed, the most efficient
translation was observed in the presence of sense dG1 and antisense dG8 that enhanced in
vitro luciferase activity over 28.1 and 55.8-fold for variant A and F, respectively (Fig 4b and
4d). At the same time, transcription levels were noted to be unchanged (Fig 4a and 4b), sug-
gesting that this regulation may differ from recently described RNAa phenomenon resulting in
up-regulation of gene transcription, induced via promoter-specific activation [29, 30] or by
promoter-directed antigene RNAs [31, 46].
In contrast to translation-enhancing dGs, their complementary partners (dG2, dG3 and
dG7) had no or opposite effects (Fig 4). Moreover, neither mismatched control dG5 nor con-
trol dG6 altered protein levels in significant way (Fig 4b and 4d). Scrambled control with a ran-
dom sequence was shown to have no effect on luciferase activity as well (Fig 4b and 4d), thus,
confirming target site-specific action of dG1, dG4 and dG8.
In studying the translational regulatory potential of TRβ1 5'UTR variants we raised the
question whether the observed translation-enhancing effects triggered by dGs are universal or
TRβ1-specific. To check this out we designed dGs against the IRES identified within the
p16INK4a 5'UTR (CDKN2A) [21] and used the dGenhancer calculator to design dGs specifi-
cally targeting the ΔG-dependent, translation-regulating elements within this 5'UTR (S1
Appendix). The CDKN2A gene is frequently mutated or deleted in a wide range of tumors and
produces at least three alternatively spliced variants encoding four distinct proteins [21]. An
analysis of translation under the control of the p16INK4a 5'UTR, which was incorporated into
a PCR-amplified linear luciferase expression construct (S1 Appendix) revealed a 4.78-fold
increase in protein levels and unchanged transcription rates after addition of dG1p16 (Fig 5).
As was found for the dG1 unblocking IRES oligo in TRβ1 5’UTR (Fig 3), the sense dG1p16
can enhance translation via binding to distant sequences that may interact through compli-
mentary base-pairing with the IRES region of the p16INK4a 5'UTR. The strongest enhancing
effects on luciferase activity (12.30-fold) were obtained by combining dG1p16 and dG6p16
(Fig 5) that is in accordance with previously observed in TRβ1 5'UTRs reactions translation-
enhancing effects triggered by a mixture of sense dG1+dG8 or dG1+dG4 unblocking an IRES
region (e1) and blocking translation-inhibitory element (e2 or e3). Although different con-
structs were used in this study, these results clearly confirm findings obtained in vitro with
TRβ1 5'UTRs and show that dGs could be used as an universal tool controlling levels of
selected proteins.
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microRNA-like dGoligos are more effective to enhance in vivo translation
These experiments were designed to investigate whether dGs can regulate protein translation
in a cellular context. We used Caki-2 cells transfected with pGL3-derived plasmid [23] carrying
TRβ1 5’UTR and downstream luciferase that allows for fast and reliable assessment of quickly
changing translation rates in these cells after treatment with dGs. In contrast to results obtained
in vitro with RNase H deficient wheat germ extracts, transfection of Caki-2 with DNA based
dGs did not alter luciferase activity (S9 Fig), likely because unmodified deoxy-oligonucleotides
are rapidly degraded by cellular nucleases [41], which can also switch off the translation in a
non-specific way [15]. The use of 2'-O-methyl RNA -modified dGs, however, influenced the
translation efficiency in these cells (Fig 6). Surprisingly, 2'-O-methyl modified, antisense,
microRNA-like dGs: dG6 and dG10, containing a 3 nucleotide long insertion (loop) in the
middle of their sequences (S3 Table), resulted in a greater than 2.6-fold and 4.8-fold increase in
luciferase activity, respectively, whereas microRNA-like sense dG5 (complementary to dG6),
sense dG9 (complementary to dG10) and scrambled control dGsc had no significant effect on
the translation (Fig 6). All tested dGs did not affect mRNA levels suggesting that they could be
involved specifically in translational control. These results are consistent with reports showing
that some naturally occurring microRNAs can bind to 5'UTRs and regulate translation initia-
tion [26, 45], however, their selectivity toward a single mRNA is thought to be low [27]. In con-
trast, synthetic micro-RNA like dGs with almost full complementarity to a target sequence and
reduced positions of potential G:U wobble base-pairing were shown to have high binding
capacity and selectivity toward the complementary sequence (S7c Fig).
dGoligo-treated cells can enhance translation of a native protein
Translation-enhancing properties of selected 2’-O-methyl-modified dGs were confirmed in
Caki-2 cells on translation of endogenous TRβ1 protein that has been reported to be a tran-
scription factor controlling transcription rates of type 1 iodothyronine deiodinase DIO1 [8].
DIO1 transcript, therefore, served as an estimate for TRβ1 transcription factor activity, which
was expected to be dependent on the TRβ1 protein levels [8, 23]. Our experiments showed that
the cells (without any plasmid) transfected with microRNA-like dG10 over-expressed the
DIO1 mRNA by 2.5-fold that was accompanied by 2.3-fold enhancement in translation of the
endogenous TRβ1 protein (Fig 7). It has also been shown that the levels of this protein can be
elevated even more using alternative methods of the dGs delivery [47]. All tested dGs had no
impact on TRβ1 mRNA levels, and treatment with scrambled control (dGsc) unchanged tran-
scription and translation rates. Therefore, the elevated levels of DIO1 mRNAmay indicate
higher transcription factor activity of TRβ1 [8, 23] in the dG-treated cells (Fig 7e) and may pro-
vide evidence that dGs can affect the functional response of the living cells.
dGoligo may interfere with machinery of translational control
Although the exact action of dGs remains unknown, it is clear that binding of these oligonucle-
otides can affect secondary and tertiary structures of a target sequence that may result in alter-
ing its translation regulating properties (Fig 3). This action is considered to trigger subsequent
mechanisms leading to translation-enhancing or -silencing effects [18, 29].
Antisense DNA oligonucleotides (ASOs) are widely used to suppress gene expression by
inducing RNase H-mediated mRNA degradation of the target mRNA [48]. The DNA/RNA
heteroduplexes are subsequently targeted for endonucleolytic cleavage by the RNase H, how-
ever, previous observations suggest that ASOs, which are usually used to target a coding
sequence, may result in RNase H-dependent generation of stable mRNA cleavage fragments
without 5’-cap, followed by expression of truncated proteins. The lack of the 5’-cap structure
AMethod for Gene-Specific Enhancement of Protein Translation
PLOS ONE | DOI:10.1371/journal.pone.0155359 May 12, 2016 16 / 23
could further be bypassed by the cap-independent but 5’ end-dependent translation, initiated
from an AUG start codon located a few nucleotides downstream of the 5’ end of the RNA frag-
ment [48]. This mechanism of translation was observed in vitro and in vivo, albeit with severely
reduced efficiency [48]. Translation of the cleavage fragments may also occur via direct binding
of ribosomes to internal RNA secondary structures (IRESs) present on various cellular
mRNAs, however, the IRES-mediated translation efficiency is condition-dependent [5, 13] (S2
Fig). These findings provide a rationale for understanding the translation of mRNA fragments
generated by RNase H and could be considered in vivo as a potential mechanism of action of
small enhancing oligonucleotides. They, as other ASOs, may interfere with the RNAse H path-
way and subsequently generate RNA cleavage fragments [48] including transcripts with
shorter, less folded 5’UTRs. However, it was also elucidated, that 2’-O-methyl sugar modifica-
tions result in an increased resistance to nuclease degradation [41, 49]. In addition, RNase H
activity in wheat germ lysates has been reported to be markedly reduced in comparison to
other mammalian-based translation systems [49]. Moreover, in our in vitro coupled transcrip-
tion/translation experiments with dGs, the levels of transcripts after 6-hour reactions were
unchanged (S3 Fig), suggesting that, indeed, RNAse H could not induce cleavage of dGoligo
target sites and probably do not have strong impact on the observed over 58-fold (dG1 and
dG8) enhancement of translation efficiency in the used in vitro system.
Comparing results from two different transcription-translation assays performed in the
plant cell-free lysates and human cells (Figs 4 and 6), we considered whether dGs could be
involved in RNAi/RNAa related phenomena. Unlike mammalian microRNAs, plant micro-
RNAs require nearly perfect base pairing to induce the RNAi machinery [39]. Our results
showed that neither microRNA-like dG5 nor dG6 altered in vitro protein levels in significant
way (Fig 4b and 4d), indicating that when the assay is performed in the plant extract, a micro-
RNA-like sequence loop introduced in the synthetic dGs can block their action. On the con-
trary to fully complementary sense/antisense-like dGs that we found to be the most effective in
the plant system (Fig 4), the antisense microRNA-like dGs exerted the strongest translation-
enhancing effects in Caki-2 cells (Fig 6). These findings are in agreement with distinct mecha-
nisms of RNA interference in mammals and plants and could serve as an argument for involve-
ment of dG-5'UTR dimmers in some elements of this machinery. Although our assumption
needs to be studied in details, it can be supported by the known action of non-selective transla-
tion-enhancing microRNAs including miR-122 [26] or miR-10a [45] and a link between
microRNA targets in 3’UTRs and 5’UTR structures that are thought to play an essential role in
RNAi [18]. Recently discovered small activating RNAs (saRNAs) [28] can also trigger mecha-
nisms leading to similar gene-enhancing effects, however, unlike our single stranded transla-
tion-enhancing dGs, saRNAs have been shown to be effective as double stranded
transcription-activating molecules targeting promoter regions [29].
Conclusion
In summary, this work presents the first evidence for gene-specific translation-enhancing
effects triggered by small selective oligonucleotides termed dGoligos (dGs). These synthetic
trans-acting factors were originally designed to alter Gibbs energy-dependent secondary struc-
ture formation of TRβ1 5’UTRs encoded by THRB suppressor gene. The applied approach
allowed us for over 55.8-fold translational enhancement of reporter protein when dG1 and
dG8 were used in coupled in vitro translation-transcription assay. Complementary in vivo
study showed that dGs can enhance TRβ1–5’UTR -mediated translation up to 4.8-fold. Inter-
estingly, this assay showed that protein can be more effectively synthesized when microRNA-
like, 2'-O-methyl RNA antisense dGs were used. Furthermore, dGenhancer calculator, which
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allowed us to determine targets within TRβ1 5’UTRs, was also successfully used to design dGs
enhancing translation of another CDKN2A tumor suppressor transcript, thus confirming the
universality and potential of dGs to over-express selected proteins. The concept of this
approach was based on our discovery that the most folded 5'UTR variants have higher transla-
tional regulatory potential that can be released to enhance translation efficiency by the use of
specific dGs. They served as a molecular switch to translationally active conformation of the
folded 5'UTRs. Taking together, this report would be the first showing a method for specific
activation of translation-enhancing elements of high regulatory potential. This strategy may
complement other available methods for gene expression regulation including gene silencing
and may find its use in enhancement of genes frequently silenced in cancers or even in biotech-
nology of recombinant proteins.
Materials and Methods
Luciferase reporter constructs
In vitro studies were performed with pBluescript-KS(+)-derived plasmid vectors containing
different TRβ1 5’UTR variants (pKS-A,-B,-C,-D,-E,-F,-G) or irrelevant leader sequence lacking
any TRβ1 UTR (pKS-control) [22]. 5'UTRs were subcloned upstream of the luciferase reporter
gene [22]. For in vivo analyses, we used pGL3-derived plasmid, carrying variant A of TRβ1
5’UTR (pGL3-A) [22], which was found to be the most predominant in kidney cells [23].
pGL3-control (without TRβ1 5’UTR) served as a control plasmid [22].
Prediction of translation-enhancing elements
Two methods were used.Manualmethod allowed us to identify higher-order structures within
5’UTR cis-acting sequences (IRESs or uORFs stretches). Folding predictions from RNAstruc-
ture version 5.2, together with sequence analysis using NCBI tools were combined to select
putative cis-acting elements containing the most stable secondary structures (the most negative
ΔG). As a second method, dGenhancer—an excel-based calculator was used to automatically
identify putative ΔG-dependent translation-regulating elements within 5'UTR sequences (S1
Appendix). The algorithms of the calculator were constructed to visualize ΔG changes after in
silico introduced single nucleotide substitutions (SNPs) of the 5’UTR sequences. These artificial
SNPs differently affected overall sequence ΔGs (Gibbs energies) that were drawn by the dGen-
hancer to show regions where substitution can alter ΔGs the most, indicating putative cis-act-
ing elements with the highest translational regulatory potential. The software that implements
the calculations can be accessed here: http://www.serwer1448847.home.pl/biotechnology/
dGenhancer.xlsx
dGoligo synthesis
Sense-, antisense- or microRNA-based DNA oligonucleotides were designed (S3 Table) to tar-
get cis-acting elements of TRβ1 5’UTRs (S1 Appendix). For in vivo studies nuclease-resistant
2'-O-methyl modified RNA oligonucleotides were synthesized. Oligonucleotides were per-
formed with ABI 3900 High-Throughput DNA Synthesizer (Applied Biosystems, Foster City,
CA) using standard DNA or 2'-O-methyl-modified phosphoramidites (Link Technologies,
Lanarkshire, UK).
Coupled in vitro transcription and translation assay
500ng of each plasmid were simultaneously transcribed and translated in 0.2mL-PCR tubes
using RTS 100 Wheat Germ CECF Kit (Roche Diagnostics, Mannheim, Germany). The
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translation assay was conducted in 20μL of Reaction Solution, supplemented with 20uL of
Feeding Solution after initial 3h-incubation. All reactions were maintained at 37°C for 6h with
shaking at 600 rpm, using the RTS ProteoMaster Instrument (Roche Applied Science, Mann-
heim, Germany). After reaction, DNA levels of appropriate pKS plasmids (plasmid copy num-
ber per each reaction) were measured by semi-quantitative Real-Time PCR and served as
internal controls of transcription and translation efficiency (S1 Appendix). mRNA levels were
determined by semi-quantitative measurement of luciferase transcripts using Real-Time PCR
(Quanti-Fast SYBR Green PCR Kit, Qiagen, Hilden, Germany) and two pairs of PCR primers
(S4 Table). The reactions were performed with LightCycler 480 (Roche, Germany) under stan-
dard conditions shown in Materials and Methods in SM. In vitro translation-enhancing assay
was performed with 500ng of pKS-A, pKS-F and pKS-control constructs were expressed as
above in the presence of 0,25μM each tested dGoligo (S3 Table) or in the absence of dGoligo
(dG-). For normalization, the results were divided by corresponding results obtained for pKS-
control, to eliminate any possible non-specific dGoligo effects. Translation efficiency was deter-
mined by the use of Luciferase Reporter Gene Assay (Promega, Madison, WI) with the Syn-
ergy2 luminometer (BioTek, Winooski, VT) in conditions recommended by the
manufacturers.
Cell-culture based, in vivo transcription and translation assay
The human clear cell renal carcinoma cell line (Caki-2) was used (American Type Culture Col-
lection, Manassas, VA). Caki-2 cells were grown in McCoy’s 5A medium with L-glutamine
(Gibco/Invitrogen, Carlsbad, Ca) with 10% fetal bovine serum (FBS; Sigma-Aldrich, Saint
Louis, MO) and 1x penicillin-streptomycin solution (Sigma-Aldrich, Saint Louis, MO). The
cells were maintained at 37°C in 5% CO2 atmosphere. For all the experiments, Caki-2 cells
were seeded into 75cm2 bottles, 6- or 12-well culture plates at density 13x103 cells/cm2, 24h
before transfection. Three independent in vivo experiments were performed in triplicate.
Luciferase expressing plasmids and dGoligo transfection
24 hours after seeding, cells were transfected with 100 ng of control pRL-TK (Promega,
Madison, WI) and 1ug of pGL3-A plasmid [22], using 1μg/ul PEI (Linear Polyethylenimine,
Polysciences Inc., Warrington, PA) and 150mMNaCl in FBS-free McCoy’s medium. Five
hours after transfection, the medium was replaced with McCoy’s medium plus 10% FBS. PEI-
mediated transfection reactions contained 36nM of each dG and was carried overnight. The
medium was then replaced with McCoy’s medium plus 10% FBS and 1x penicillin-streptomy-
cin solution. 24h after the last medium replacement, cells were harvested. The cells were
divided into two equal parts for isolation of total RNA and luciferase protein. The RNA was
processed as described below.Dual-luciferase assay. The protein measurements were per-
formed using dual-luciferase assay (Promega, Madison, WI) in the Synergy2 luminometer
(BioTek, Winooski, VT), according to the manufacturer’s instructions.
Cellular RNA isolation
Total RNA for real-time PCR was purified from the second part of the collected cells as it was
described for in vitro assay.
Reverse transcription and Semi-Quantitative Real-time PCR
Reverse transcription and Real-time PCR of luciferase pGL3-A and pRL-TK control was per-
formed according to the protocol used for in vitro study. The transcript levels of Firefly
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luciferase were compared with Renilla using specific primers (S4 Table). Relative changes in
gene expression were calculated using the 2(-ΔΔCt).
dGoligo controls
All dGs were tested as complementary sense and antisense sequences (S3 Table). dG5, dG6,
dG7 and dG8 were synthesized as mismatched controls containing a 3 nucleotide-long mis-
matched insertion in the middle of the oligonucleotides (Fig 2). An additional scrambled con-
trol oligonucleotide (dGsc) with an irrelevant (random) sequence was as designed with
GeneScript software (S3 Table).
Bioinformatic analysis
Total Gibbs energy prediction (ΔG = ΔH—TΔS) of 5’UTR secondary structures was performed
using RNAstructure version 5.2 [37]. NCBI-BLASTN program and IRESite database [38] were
used for comparative sequence analysis towards evolutionary conserved 5’UTR domains such
as IRES consensus sequences. The dGenhancer calculator was used to determine translation
regulating elements (S1 Appendix).
Statistics
At least three independent experiments were carried out for each assay and measured in tripli-
cate. Normality of data distribution was estimated using Shapiro-Wilk test and in each case
data were analyzed by ANOVA followed by Dunnett’s multiple comparison test. p<0.001 was
considered statistically significant. Correlation of Gibbs energy and translation efficiency (Fig
1c) was estimated by r-squared value of the Pearson product-moment correlation coefficient.
Logarithmically transformed data of translation efficiency were analyzed with the Gibbs ener-
gies by linear regression. p<0.05 was considered statistically significant.
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